Drug Type Biological products |
Synonyms KKD001 |
Target- |
Action- |
Mechanism- |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Glomerulonephritis, IGA | Phase 1 | China | 07 Nov 2025 | |
| Glomerulonephritis, Membranoproliferative | Phase 1 | China | 07 Nov 2025 | |
| Glomerulonephritis, Membranous | Phase 1 | China | 07 Nov 2025 | |
| Glomerulosclerosis, Focal Segmental | Phase 1 | China | 07 Nov 2025 | |
| Multiple Sclerosis | Phase 1 | China | 07 Nov 2025 | |
| Nephrosis, Lipoid | Phase 1 | China | 07 Nov 2025 | |
| Nephrotic Syndrome | Phase 1 | China | 07 Nov 2025 | |
| Proteinuria | Phase 1 | China | 07 Nov 2025 |





